Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization

[1]  Kihyun Kim,et al.  Single‐dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma , 2019, Journal of clinical apheresis.

[2]  M. Ooi,et al.  Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myeloma. , 2018, Hematology/oncology and stem cell therapy.

[3]  Wei Zhu,et al.  Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis , 2018, Cell Death & Disease.

[4]  Hong Zhou,et al.  c‑Myc promotes cholangiocarcinoma cells to overcome contact inhibition via the mTOR pathway. , 2017, Oncology reports.

[5]  L. Andritsos,et al.  A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation , 2016, Bone Marrow Transplantation.

[6]  J. Lévesque,et al.  Cellular players of hematopoietic stem cell mobilization in the bone marrow niche , 2017, International Journal of Hematology.

[7]  Yong Park,et al.  CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities , 2016, Stem cells and development.

[8]  D. Piktel,et al.  In Vitro Expansion of Bone Marrow Derived Mesenchymal Stem Cells Alters DNA Double Strand Break Repair of Etoposide Induced DNA Damage , 2016, Stem cells international.

[9]  M. Ooi,et al.  Vinorelbine-Cyclophosphamide Compared to Cyclophosphamide in Peripheral Blood Stem Cell Mobilization for Multiple Myeloma , 2015 .

[10]  A. Trumpp,et al.  Posttranscriptional regulation of c-Myc expression in adult murine HSCs during homeostasis and interferon-α-induced stress response. , 2014, Blood.

[11]  Renu Malhotra,et al.  IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples , 2014, PloS one.

[12]  S. Morrison,et al.  The bone marrow niche for haematopoietic stem cells , 2014, Nature.

[13]  J. H. Lee,et al.  High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  R. Foà,et al.  Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy , 2013, Clinical Cancer Research.

[15]  W. Wood,et al.  Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT , 2013, Bone Marrow Transplantation.

[16]  J. Błasiak,et al.  [Role of DNA methylation in colorectal cancer]. , 2013, Postepy biochemii.

[17]  L. Marquez-Curtis,et al.  Hematopoietic Stem Cell Mobilization and Homing after Transplantation: The Role of MMP-2, MMP-9, and MT1-MMP , 2012, Biochemistry research international.

[18]  J. Panetta,et al.  Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT , 2012, Bone Marrow Transplantation.

[19]  W. Wood,et al.  Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  G. Haraldsen,et al.  The murine IL‐8 homologues KC, MIP‐2, and LIX are found in endothelial cytoplasmic granules but not in Weibel‐Palade bodies , 2010, Journal of leukocyte biology.

[21]  I. Bernstein,et al.  Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. , 2008, Cell stem cell.

[22]  Y. Wang,et al.  Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization , 2008, Bone Marrow Transplantation.

[23]  Ido D. Weiss,et al.  Enhanced Unique Pattern of Hematopoietic Cell Mobilization Induced by the CXCR4 Antagonist 4F‐Benzoyl‐TN14003 , 2007, Stem cells.

[24]  G. Milone,et al.  Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m2 plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients , 2007, Leukemia & lymphoma.

[25]  S. Fukuda,et al.  Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. , 2006, Experimental hematology.

[26]  G. Bridger,et al.  A Pharmacokinetic‐pharmacodynamic Model for the Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100 , 2005, Clinical pharmacology and therapeutics.

[27]  Mark J. Murphy,et al.  c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. , 2004, Genes & development.

[28]  Y. Lau,et al.  Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents , 2004, British journal of haematology.

[29]  P. Sansonetti,et al.  IL-8 Is a Key Chemokine Regulating Neutrophil Recruitment in a New Mouse Model of Shigella-Induced Colitis , 2004, The Journal of Immunology.

[30]  F. Behm,et al.  Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment. , 2003, Blood.

[31]  Michelle L. Varney,et al.  IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 , 2003, The Journal of Immunology.

[32]  E. Jantunen,et al.  Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma , 2003, Bone Marrow Transplantation.

[33]  J. Lévesque,et al.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. , 2003, The Journal of clinical investigation.

[34]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[35]  D. Link,et al.  Stem cell mobilization. , 2003, Hematology. American Society of Hematology. Education Program.

[36]  A. Mantovani,et al.  Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Pavone,et al.  Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma , 2002, Bone Marrow Transplantation.

[38]  T. Klingebiel,et al.  Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens , 2002, Anti-cancer drugs.

[39]  K. Kurosaka,et al.  Cytokine production by macrophages in association with phagocytosis of etoposide-treated P388 cells in vitro and in vivo. , 2001, Biochimica et biophysica acta.

[40]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[41]  L. Hang,et al.  Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. , 2000, The Journal of infectious diseases.

[42]  P. Ljungman,et al.  The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity , 2000, Bone Marrow Transplantation.

[43]  C. Figdor,et al.  The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization. , 2000, Seminars in hematology.

[44]  R. Willemze,et al.  Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  V. Diehl,et al.  Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization , 1999, Bone Marrow Transplantation.

[46]  C. Figdor,et al.  Biology of IL‐8‐Induced Stem Cell Mobilization , 1999, Annals of the New York Academy of Sciences.

[47]  J. Talmadge,et al.  Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. , 1999, Blood.

[48]  C. Bokemeyer,et al.  Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  L. Gibson,et al.  Disruption of bone marrow stromal cell function by etoposide. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[50]  I. Weissman,et al.  Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Roberts,et al.  Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. , 1995, Blood.

[52]  R. Willemze,et al.  Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. , 1995, Blood.

[53]  M. Cassatella.  The production of cytokines by polymorphonuclear neutrophils. , 1995, Immunology today.

[54]  A. Zander,et al.  Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  M. Baggiolini,et al.  Interleukin‐8, a chemotactic and inflammatory cytokine , 1992, FEBS letters.

[56]  M. Baggiolini,et al.  IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. , 1992, Journal of immunology.

[57]  J. Villeval,et al.  Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. , 1988, Blood.

[58]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .